PDA

View Full Version : General Cancer News


Pages : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 [17] 18 19 20 21 22 23 24 25 26 27 28 29 30

  1. Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicar
  2. Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45
  3. FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment
  4. NIH awards RXi with SBIR grants to develop novel RNAi therapeutics
  5. Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer
  6. CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC
  7. Maternal consumption of omega-3 fatty acids during pregnancy reduces risk of childhoo
  8. New nanoparticle imaging agent can help diagnose heart disease, breast cancer
  9. Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausa
  10. FOIA request on Avastin filed with the FDA
  11. Celgene non-GAAP total revenue increases 40% to $1.11 billion
  12. FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced
  13. New PET imaging clinical trial to improve early esophageal, lung cancer detection
  14. New innovative pilot project to combat surgical infections
  15. MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals
  16. Researchers discover possible role of SCCA in breast cancer progression
  17. UMMS, RXi receive MLSC grant to develop RNAi therapeutics for ALS
  18. Reimbursement policy influences choice of IMRT for treating breast cancer
  19. Annual mammogram sufficient follow-up after BCT for breast cancer patients
  20. FDA approves Abbott's AndroGel for hypogonadism treatment in men
  21. IMPAKT 2011 conference to highlight new breast cancer studies
  22. Mammography screening can benefit women under age 50
  23. MarginProbe System meets its primary endpoints: Dune Medical Devices
  24. Alcohol and raised cancer risk: Report
  25. USPSTF recommendations negatively impact yearly mammograms among 40-49 year old women
  26. Watson launches Generess Fe low-dose oral contraceptives in the U.S.
  27. Statins can play crucial role to reduce lung damage in severe abdominal sepsis
  28. McMaster receives new Canadian Cancer Society grants for groundbreaking research
  29. Tecnologie Avanzate, Naviscan sign deal to distribute PET scanner in Italy
  30. Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma
  31. FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patie
  32. FDA clears Sectra's digital mammography system
  33. ChipDX identifies gene expression signature in early-stage breast tumors
  34. Breast shields can protect women from radiation exposure during CT exams
  35. Researchers identify regulatory protein that can inhibit cancer metastasis
  36. Researchers discover new mechanism by which BRCA1 gene mutations can induce breast ca
  37. New poll: 57% of women believe mammograms should start at age 40
  38. Researchers identify unexpected triple-negative breast cancer marker
  39. Two breast cancer genomic tests produce broadly similar results for high and low-risk
  40. Insight into breast cancer
  41. Genome epigenetic analysis reveals new ways to detect and treat breast cancer
  42. Clinical study: Celecoxib drug may treat breast cancer
  43. ZIOPHARM reports net loss of $39.0 million for first quarter 2011
  44. CytRx reports $6.3 million net loss for first quarter 2011
  45. CanTeen launches groundbreaking cancer support system
  46. Mammogram appointments delayed by up to 148 days: NYC report
  47. CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society mee
  48. UT Southwestern researcher identifies estrogen's effect on breast cancer cells
  49. AGA honors four young gastroenterologists with prestigious Research Scholar Awards
  50. First Edition: May 6, 2011
  51. All California women can find affordable preventive care options
  52. Study confirms prognostic role of CTC in metastatic breast cancer
  53. New stem cell finding opens door for novel triple negative breast cancer therapies
  54. Study analyzes breast-feeding frequency of infants in eight inner-city Philadelphia h
  55. Breast cancer linked to lifestyle & three new genes
  56. Mary Ann Liebert publishes new journal on cancer care for adolescent and young adult
  57. GTx reports net loss of $2.6 million for first quarter 2011
  58. Acceleron presents RAP-661 preclinical data in osteopenic mice at International meeti
  59. Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in
  60. Rapid blood-based test can determine patients with SLE
  61. Seven-time Tour de France champion to raise funds for CBCF's cancer research initiati
  62. Coffee consumption can reduce risk of ER-negative breast cancer in women
  63. Breast cancer and unhealthy lifestyle choices
  64. Genetic test to identify women at higher risk of breast cancer could reduce risks ass
  65. Women with invasive breast cancer can benefit from new genomic test
  66. ImmunID, Cytheris commence CYT107 and XELODA Phase IIa trial in metastatic breast can
  67. INESC Porto, FC and FMUP to hold international seminar on breast cancer
  68. Researchers look for surrogate endpoints to predict early benefit of cancer drugs
  69. INESC Porto, FEUP develop software to automatically analyse and validate mammograms
  70. Major upgrades to somo•v Automated Breast Ultrasound System to be showcased at SBI Me
  71. Biocept's paper describes identification of different CTC phenotypes in cancer patien
  72. Coffee provides protections from a type of breast cancer: Study
  73. ACR to honor UCLA cancer researcher with Gold Medal for radiology work
  74. ACS, PGi celebrate 10 years of partnership on key cancer initiatives
  75. Rethink praises Ontario's decision to provide breast cancer patients with Herceptin
  76. ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer
  77. New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20
  78. NewGene develops breakthrough test for hereditary breast cancer
  79. International researchers discover new aspect of 'metabolic transformation'
  80. PGT, Quintiles collaborate to bring genomic testing into mainstream drug development
  81. New biomarker can predict breast cancer recurrence
  82. Cytori Therapeutics announces independent clinical study results in breast reconstruc
  83. New avenue for treating breast cancer
  84. Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prosta
  85. CITN selects Cytheris' CYT107 for initial clinical trials at network institutions
  86. Clinical PET system for early stage breast cancer diagnosis
  87. U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound
  88. Estradiol may exacerbate tumor growth in breast cancer
  89. Yoga offers unique benefits beyond fighting fatigue for women with breast cancer
  90. Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancer at ASCO annua
  91. New breast cancer biomarker may help identify women's response to tamoxifen
  92. APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage
  93. On Op-Ed pages, controversies abound: Romney, Gingrich, abortion, telemedicine, cance
  94. Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO ann
  95. AstraZeneca announces encouraging results from olaparib phase II study in serous ovar
  96. Simple home-based colon cancer screening test can prevent many unnecessary deaths in
  97. RXi to present updated NeuVax Phase II trial data in breast cancer at ASCO 2011
  98. Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate
  99. Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer
  100. Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast
  101. EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA
  102. Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual M
  103. Breast cancer survivors, advocates stress importance of Every Woman Counts program
  104. FDA approves SUTENT for treatment of pancreatic NET
  105. Researchers identify new drug resistant protein in breast cancer
  106. Scientists find new drug target in breast cancer
  107. Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results i
  108. Variant of obesity gene may increase breast cancer risk
  109. Researchers discover protein switch that can trigger heart failure
  110. Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of
  111. Most Cancer Patients Like Full Access to Records
  112. Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast c
  113. Lipofilling seems to be safe procedure for breast cancer patients, study suggests
  114. Neoprobe, Devicor sign gamma detection device asset purchase agreement
  115. Low vitamin D could account for link between obesity and cancer, heart disease, diabe
  116. Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASC
  117. Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive brea
  118. Folic acid during pregnancy reduces rate of colon cancer in offspring
  119. Tacrolimus prevents breast cancer growth in pre-clinical studies
  120. Lactate shuttle also exists in human tumors
  121. Nutribar, CBCF partner to support breast cancer research
  122. New insights into pathogenesis and treatment of hereditary breast, ovarian cancer
  123. Novartis employees to do volunteer work for non-profit groups during 15th annual Comm
  124. Canadian women more aware of ovarian cancer now, but misconceptions remain
  125. Two Almac's main research projects on ovarian, breast cancer to be presented at ASCO
  126. Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer
  127. Latest Breast cancer screening guidelines deemed unsafe by 80% women
  128. Type II diabetes drug may slow or stop breast cancer tumor metastasis
  129. IPSOGEN announces two studies on Genomic Grade test to be presented at ASCO 2011
  130. Breast fat transfer procedure can achieve twofold increase in breast size
  131. Researchers discover overactive genes that drive triple-negative breast cancer cells
  132. Data from final analysis of AVEO's tivozanib Phase 2 trial in kidney cancer presented
  133. Elevated CRP levels predict poor prognosis of breast cancer
  134. Syndax receives U.S. patent for entinostat to treat metastatic cancers
  135. Many women over 70 with stage I breast cancer opt for radiation therapy: ASCO
  136. Telethermographic device is not approved for screening breast cancer
  137. Nuvera announces results of blinded study on breast cancer assay for taxane chemother
  138. Princess Margaret Hospital Foundation, Canadian Cancer Society to raise funds towards
  139. PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study
  140. Thermography should not be used instead of mammography for breast cancer screening, F
  141. Additional data supporting utility of PAM50 gene signature for breast cancer to be pr
  142. Researcher to evaluate new approach for treatment of triple-negative breast cancer
  143. Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2
  144. HRT reduces risk of breast cancer in women with BRCA mutations after ovary removal
  145. Starving breast cancer cells of hedgehog significantly slows tumour growth and spread
  146. Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Meno
  147. U of A researchers try to combat heart disease in cancer patients
  148. Exemestane reduces risk of breast cancer in high-risk, postmenopausal women
  149. Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011
  150. Ipsen decides to assess development of Irosustat in combination with hormonal therapi
  151. Women with breast cancer do not benefit from flaxseed
  152. Anti-Mullerian hormone test can indicate reproductive function in young women with ca
  153. Additional radiation treatment holds promise for breast cancer surgery patients
  154. Study suggests strong link between dying from breast cancer and being obese
  155. NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011
  156. GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patie
  157. AstraZeneca receives AmeriCares' Power of Partnership Award for global health program
  158. Positive results from RXi NeuVax Phase 2 trial on breast cancer presented at ASCO 201
  159. Teva's lipegfilgrastim-pegfilgrastim comparative Phase III study in breast cancer mee
  160. Manhattan acquires Senior Scientific
  161. APP to commence marketing Letrozole Tablets for breast cancer in the U.S.
  162. Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011
  163. Scientists discover key molecule that targets tumour blood vessels
  164. Increases in VEGF-family markers in metastatic colorectal cancer patients associated
  165. Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breas
  166. FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold
  167. Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 st
  168. Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced
  169. ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO
  170. Mother's blueberry consumption can improve mammary gland health in offspring
  171. NYU Cancer Institute scientists present new research findings at ASCO 2011
  172. Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer present
  173. Health-care professionals, researchers to attend Sixth World Conference on Breast Can
  174. U.S. cancer drugs shortage has doctors scrambling
  175. Researchers identify key molecule responsible for breast tumor metastasis
  176. New NCIN report: Poorer women more likely to die from breast cancer
  177. Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting
  178. Scientists uncover new role for key cancer protein
  179. Sulforaphane-rich foods safe and effective for preventing cancer
  180. FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma
  181. Spanish scale measures concern about cancer in healthy people
  182. Surgeon uses radiotracer to detect the ganglion through which tumour attempts to spre
  183. LA/hypnosis combination during surgery can aid healing process, reduce drug use and h
  184. McMaster researchers: Routine autism screening not needed for children
  185. Roundup: States controlled by GOP pass sweeping changes; state budgets still very lea
  186. Ventana Medical receives FDA approval for new breast cancer genetic test
  187. Change in diet can reduce cancer risk
  188. Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer
  189. QIAGEN to acquire Ipsogen
  190. Statistics of breast cancer risk
  191. Childhood cancer survivors at increased risk of new cancers in middle age
  192. Magnesium essential for absorption and metabolism of vitamin D and calcium
  193. Sheep diagnoses breast cancer
  194. Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conf
  195. State roundup: Mass. health spending's rise; huge Ky. hospital merger
  196. Train the brain to manage chronic pain
  197. Older women in the UK less likely to have surgery for breast cancer than younger ones
  198. Study shows deprivation leads to cancer inequality in England
  199. Food-based soy products safe for breast cancer survivors, expert says
  200. Scientists create first roadmap to understand estrogen signaling in breast cancer cel
  201. Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hea
  202. Cancer Statistics 2011 report finds not all segments of the population have benefitte
  203. Two thirds of women with breast cancer more likely to die from cardiovascular disease
  204. Novel biomarker-development pipeline approach for human diseases
  205. Panacea Global announces name change
  206. Genetic Technologies introduces BREVAGen genetic test for assessing non-familial brea
  207. California-born Asian and Pacific Islander women face higher risks of breast cancer
  208. Nine young clinical investigators earn recognition from Damon Runyon Cancer Research
  209. ImmunoCellular Therapeutics at World Cancer Vaccines Summit (6/23/11, Boston)
  210. BHGI, Shanghai CDC to form Breast Health Resource Center in China
  211. Proton beam radiotherapy appears to control breast cancer with minimal side-effects
  212. Silicone gel-filled breast implants: FDA releases updated data
  213. CHW interventions linked to increased rates of mammography screening
  214. Unavailability of Avastin more dangerous risk for breast cancer patients, says FAMEDS
  215. New model estimates impact of lifestyle changes on absolute breast cancer risk
  216. Philips to acquire Sectra's mammography modality operations
  217. Many women with advanced breast cancer do not receive radiation after mastectomy
  218. Study aims to find out whether blood screening can diagnose early breast cancer
  219. First Edition: June 27, 2011
  220. Androgen receptors trigger cancer cell growth in oestrogen-receptor-negative breast c
  221. Researchers demonstrate how Runx3 protein could suppress breast cancer tumor growth
  222. Mammography screening prevents breast cancer deaths in women
  223. FDA hearing on breast cancer drug set for this week
  224. Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer
  225. Women can benefit from immediate breast reconstruction following mastectomy
  226. Researchers, policy experts to examine issue of declining enrollment in clinical tria
  227. Breast cancer patients not getting recommended radiation therapy: Report
  228. Many advanced breast cancer patients do not receive postmastectomy radiation therapy
  229. First Edition: June 28, 2011
  230. Screening with mammography reduces deaths from breast cancer
  231. Conventional Estrogen Receptor measurement methods may result in 10-20% false negativ
  232. New prostate cancer drugs bring cost of care into spotlight
  233. PEP intervention increases breast cancer awareness
  234. Patients, scientists in different corners for cancer drug fight
  235. FDA looks at Avastin risks
  236. Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate
  237. FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer
  238. Provectus presents additional data on PV-10 at two separate melanoma conferences
  239. TCGA examines ovarian serous adenocarcinoma tumors from 500 patients
  240. New technology reduces stress of scheduling chemotherapy treatments
  241. First Edition: June 30, 2011
  242. Positive results from Nexavar Phase 2b trial on breast cancer presented at ASCO
  243. Panel advises FDA to reject Avastin as breast cancer drug
  244. Avastin for breast cancer still covered by Medicare despite FDA indecision
  245. Scientists discover enzyme that can regulate breast cancer development
  246. Two defective genes may cause telomere elongations in cancer cells: Study
  247. Six new scientists to receive SWCRF grants for cancer research
  248. First Edition: July 1, 2011
  249. Medicare to cover 2 expensive cancer drugs
  250. Medical practitioners can help reduce breast cancer deaths in African-American women